(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 3.81% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.64%.
Sotera Health Co's revenue in 2024 is $1,098,186,000.On average, 3 Wall Street analysts forecast SHC's revenue for 2024 to be $313,019,819,352, with the lowest SHC revenue forecast at $312,546,851,401, and the highest SHC revenue forecast at $313,438,976,578. On average, 3 Wall Street analysts forecast SHC's revenue for 2025 to be $334,353,222,878, with the lowest SHC revenue forecast at $332,742,866,129, and the highest SHC revenue forecast at $336,605,909,754.
In 2026, SHC is forecast to generate $358,366,683,721 in revenue, with the lowest revenue forecast at $356,861,399,494 and the highest revenue forecast at $359,871,967,949.